After a 14-year court case, Dr. August Wolff obtains with Oppenhoff & Part-ner’s aid an ECJ ruling authorising the marketing of the drug Linoladiol N
A fourteen-year-old lawsuit concerning marketing authorisa-tion restrictions for the drug Linoladiol N of the company Dr. August Wolff GmbH & Co. KG Arzneimittel came to a close at the end of March 2019 before the European Court of Justice (ECJ).
Oppenhoff & Partner honoured as the most innovative employer for young lawyers
The commercial law firm Oppenhoff & Partner has been honoured as the most innovative employer for young lawyers. The prestigious careers magazine azur has awarded the Innovation Award 2019 to Oppenhoff for the firm’s sustained commitment to the promotion of young legal talent.
Oppenhoff & Partner has compiled a brief overview of the most pressing legal problems and possible solutions in cross-border corporate law for you. You will be forwarded to https://www.oppenhoff-brexit.eu/?lang=en